Dogecoin Cash, Inc. (DOGP) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · United States
Dogecoin Cash, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 738,907.00 USD |
| Gross profit | 473,203.00 USD |
| Operating income | -546,703.00 USD |
| EBIT | -9.95 m USD |
| Net income | -10.04 m USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Dogecoin Cash, Inc.
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
More stocks
- Onar Holding Corp (ONAR)
- Kairos Pharma, LTD. (KAPA)
- VOLITIONRX LTD (VNRX)
- B-Scada, Inc. (SCDA)
- Hubilu Venture Corp (HBUV)
- AXIM BIOTECHNOLOGIES, INC. (AXIM)
- EHTI Eurasia High Technology Industries (LP2.DU)
- Bone Biologics Corp (BBLG)
- Change Agents Corporation. (CHGA)
- Flash Sports & Media Holdings, Inc. (FLZH)
- SKINVISIBLE, INC. (SKVI)
- Maitong Sunshine Cultural Development Co., Ltd (MGSD)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.